The National Center for Advancing Translational Sciences is doling out $12.7 million in new grants to nine academic research teams that will try to come up with new uses for existing compounds that are owned by major pharmaceutical firms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

An NCATS License

Making the Most

Hoping for More

Mining Data Mountains

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.